Total Payments
$429.36
2024 Payments
$133.35
Companies
14
Transactions
20
Medicare Patients
1,861
Medicare Billing
$224,668
Payment Breakdown by Category
Food & Beverage$395.58 (92.1%)
Education$33.78 (7.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $395.58 | 18 | 92.1% |
| Education | $33.78 | 2 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BARD PERIPHERAL VASCULAR, INC. | $85.74 | 1 | $0 (2019) |
| Horizon Therapeutics plc | $45.67 | 3 | $0 (2023) |
| Amgen Inc. | $45.59 | 2 | $0 (2024) |
| Genentech USA, Inc. | $39.54 | 3 | $0 (2018) |
| Travere Therapeutics, Inc. | $33.78 | 2 | $0 (2024) |
| Mozarc Medical US LLC | $29.68 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $24.62 | 1 | $0 (2022) |
| Alnylam Pharmaceuticals Inc. | $24.18 | 1 | $0 (2024) |
| BAXTER HEALTHCARE | $22.28 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $18.41 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $133.35 | 7 | Amgen Inc. ($45.59) |
| 2023 | $109.54 | 6 | Horizon Therapeutics plc ($45.67) |
| 2022 | $24.62 | 1 | Daiichi Sankyo Inc. ($24.62) |
| 2019 | $85.74 | 1 | BARD PERIPHERAL VASCULAR, INC. ($85.74) |
| 2018 | $51.53 | 3 | BAXTER HEALTHCARE ($22.28) |
| 2017 | $24.58 | 2 | Genentech USA, Inc. ($24.58) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Genetic Disease | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 04/22/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Inflammation | ||||||
| 03/12/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 02/16/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Inflammation | ||||||
| 11/03/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: KRYSTEXXA | ||||||
| 10/12/2023 | NxStage Medical, Inc. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Nephrology | ||||||
| 08/11/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: KRYSTEXXA | ||||||
| 07/12/2023 | Mozarc Medical US LLC | CHAMELEON (Device) | Food and Beverage | Cash or cash equivalent | $29.68 | General |
| Category: DIALYSIS CATHETERS | ||||||
| 03/29/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEPHROLOGY | ||||||
| 03/14/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: KRYSTEXXA | ||||||
| 10/22/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/10/2019 | BARD PERIPHERAL VASCULAR, INC. | — | Food and Beverage | In-kind items and services | $85.74 | General |
| 11/16/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Gout/Rheumatology | ||||||
| 10/26/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: BioOncology/Immunology | ||||||
| 10/12/2018 | BAXTER HEALTHCARE | Renal - CRRT (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Renal | ||||||
| 06/30/2017 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: BioOncology/Immunology | ||||||
| 02/24/2017 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: BioOncology/Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 410 | 674 | $124,656 | $46,972 |
| 2022 | 7 | 204 | 328 | $61,557 | $23,240 |
| 2021 | 10 | 523 | 961 | $174,215 | $64,343 |
| 2020 | 11 | 724 | 1,319 | $245,406 | $90,113 |
Total Patients
1,861
Total Services
3,282
Medicare Billing
$224,668
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 121 | $26,620 | $10,239 | 38.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 79 | 146 | $18,834 | $8,554 | 45.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 55 | 146 | $28,908 | $7,672 | 26.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 57 | $20,520 | $7,268 | 35.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 63 | $11,718 | $5,519 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 49 | $6,272 | $2,831 | 45.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $7,320 | $2,648 | 36.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 45 | 62 | $4,464 | $2,241 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 170 | $37,400 | $14,564 | 38.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 47 | $6,063 | $2,497 | 41.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 14 | 35 | $6,930 | $1,914 | 27.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 17 | $4,148 | $1,703 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 28 | $3,584 | $1,556 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,212 | $961.68 | 29.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 20 | $220.00 | $44.62 | 20.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 137 | 351 | $45,279 | $18,758 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 151 | $33,220 | $12,358 | 37.2% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 77 | 210 | $41,580 | $11,259 | 27.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 69 | 79 | $19,276 | $7,882 | 40.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 48 | 49 | $17,640 | $7,233 | 41.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 45 | $8,370 | $3,253 | 38.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,380 | $1,779 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 21 | $2,688 | $1,347 | 50.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 22 | $1,584 | $432.78 | 27.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 18 | 18 | $198.00 | $40.50 | 20.5% |
About Dr. Duc Vu, M.D
Dr. Duc Vu, M.D is a Nephrology healthcare provider based in Kingsport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770573172.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Duc Vu, M.D has received a total of $429.36 in payments from pharmaceutical and medical device companies, with $133.35 received in 2024. These payments were reported across 20 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($395.58).
As a Medicare-enrolled provider, Vu has provided services to 1,861 Medicare beneficiaries, totaling 3,282 services with total Medicare billing of $224,668. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Kingsport, TN
- Active Since 10/26/2005
- Last Updated 01/28/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1770573172
Products in Payments
- KRYSTEXXA (Biological) $45.67
- TAVNEOS (Drug) $45.59
- Rituxan (Biological) $39.54
- CHAMELEON (Device) $29.68
- INJECTAFER (Drug) $24.62
- GIVLAARI (Drug) $24.18
- Renal - CRRT (Device) $22.28
- JESDUVROQ (Drug) $18.41
- LIBERTY SELECT CYCLER (Device) $15.78
- Fabhalta (Drug) $15.72
- Uloric (Drug) $14.29
- JARDIANCE (Drug) $14.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Kingsport
Sharan Kanakiriya
Nephrology — Payments: $11,917
Nephrology $11,917
Dr. Steven Butler, M.d, M.D
Nephrology — Payments: $1,616
Nephrology $1,616
Dr. Sathiyendran Poobalasingham, Md, MD
Nephrology — Payments: $1,576
Nephrology $1,576
Dr. Abrar Ahmad, M.d, M.D
Nephrology — Payments: $1,564
Nephrology $1,564